Triethylamine → Diethyl 3-tert.butyl-2-isoxazolin-5-ylphosphonate
반응식
[CH:1](=[N:6][OH:7])[C:2]([CH3:5])([CH3:4])[CH3:3].ClN1C(=O)CCC1=O.[CH:16]([P:18](=[O:25])([O:22][CH2:23][CH3:24])[O:19][CH2:20][CH3:21])=[CH2:17].C(N(CC)CC)C>ClCCl.N1C=CC=CC=1>[C:2]([C:1]1[CH2:17][CH:16]([P:18](=[O:25])([O:22][CH2:23][CH3:24])[O:19][CH2:20][CH3:21])[O:7][N:6]=1)([CH3:5])([CH3:4])[CH3:3]참가 물질
7
실험 절차
The procedure is analogous to that of Example 25 using 15.2 g (0.15 mol) of pivalaldoxime, 22.0 g (0.165 mol) of N-chlorosuccinimide, 0.5 ml of pyridine, 27.1 g (0.165 mol) of diethyl vinylphosphonate and 22.9 ml (0.165 mol) of triethylamine in dichloromethane. The product is obtained as an oil after the usual working up.
후처리
- customThe product is obtained as an oil after the
출처 및 근거
- ORD 기록
- ord-f7ff29b72e2e4375b1d0bcfc664d7b01
- 출처 데이터셋
- uspto-grants-1991_04
- 특허 번호
- US05006515
반응 노트
불러오는 중…